Stock screenerAll disclosures →
EDGAR →
LFCR
Conviction 62HealthcareScan · Thu, Jun 25, 2026Bearish engulfing
LFCR$5.39-7.07%
ResistanceSupportVol 14Vol MA14 160.82K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price5.39
Change-7.07%
Gap+0.26%
Rel volume1.64×
Avg volume190.71K
Avg $ vol1.04M
SMA 205.49
SMA 505.14
SMA 2006.56
Price vs 50+4.77%
Price vs 200-17.79%
MA stackmixed
50/200 cross—
Supertrendup · 4.98
RSI (14)51
MACD hist-0.02
MACD crossbear · 0d
Stoch %K / %D21 / 53
ADX (14)15
+DI / −DI23 / 22
RSI divergence—
MACD divergence—
ATR %+5.48%
ADR %5.41%
52w high8.82
52w low3.66
From 52w high-38.89%
Above 52w low+47.27%
New 52w highNo
SqueezeOff
Bollinger width18.76%
%B0.40
Donchian pos51.69%
Donchian high5.96
Donchian low4.78
AVWAP (52w high)5.11
vs AVWAP high+5.45%
AVWAP (52w low)4.87
vs AVWAP low+10.63%
OBV trendUp
Chaikin MF (20)-0.04
Today vs 20d1.64×
Avg vol (14d)160.82K
Avg vol (20d)190.71K
Avg $ vol (20d)1.04M
Market cap202.18M
RS 3m (vs SPY)+32.74%
RS 6m (vs SPY)-35.60%
RS line new highYes
Trend template3/8
Technical rank37.5
1 week-2.36%
1 month+12.29%
3 months+28.64%
6 months-34.03%
1 year-34.90%
YTD-30.36%
P/E-5.22
P/B-7.11
P/S0.36
P/FCF-14.84
EPS-1.27
Div yield—
ROE136.15%
ROA-17.17%
Debt/Eq-3.92
Current3.79
EV/EBITDA-31.77
Gross margin7.23%
Net margin-6.94%
Rev growth6.36%
EPS growth-422.29%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value292.87M
Revenue126.38M
Net income-14.98M
Gross profit4.46M
Free cash flow-13.62M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out37.51M
Employees382
ListedThu, Feb 15, 1996
Free float24.24M
Float %64.6%
Short interest2.35M
Days to cover12.7d
Short volume3.3%
Squeeze score54 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.43 vs −$0.24
Last surprise-79.2% miss
Setup gradeB
Conviction62 / 100
Pattern quality—
Tech rank37.5 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBearish engulfing
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in LFCR
No recent disclosed trades by Congress in LFCR. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in LFCR · 4 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Legion Partners Holdings, LLC Director · Common Stock · 2026-06-04 | Grant | 25.91K | — | 2026-06-04 | 2026-06-08 |
Kiper Christopher S Director · Common Stock · 2026-06-04 | Grant | 25.91K | — | 2026-06-04 | 2026-06-08 |
Legion Partners Asset Management, LLC Director · Common Stock · 2026-06-04 | Other | — | — | 2026-06-04 | 2026-06-08 |
Legion Partners, L.P. II Director · Common Stock · 2026-06-04 | Grant | 25.91K | — | 2026-06-04 | 2026-06-08 |
White Raymond T. Director · Common Stock · 2026-06-04 | Other | — | — | 2026-06-04 | 2026-06-08 |
Kiper Christopher S Director · Common Stock · 2026-06-04 | Other | — | — | 2026-06-04 | 2026-06-08 |
Legion Partners, LLC Director · Common Stock · 2026-06-04 | Other | — | — | 2026-06-04 | 2026-06-08 |
Legion Partners, LLC Director · Common Stock · 2026-06-04 | Grant | 25.91K | — | 2026-06-04 | 2026-06-08 |
Legion Partners Holdings, LLC Director · Common Stock · 2026-06-04 | Other | — | — | 2026-06-04 | 2026-06-08 |
Legion Partners, L.P. I Director · Common Stock · 2026-06-04 | Other | — | — | 2026-06-04 | 2026-06-08 |
SEC filings
EDGAR filings in LFCR · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.